Rapid change in diagnostics and laboratory research tools—including next-generation sequencing, personalized medicine, and point of care technology, among other trends—have created new opportunities for forward-thinking companies.
As tools and technologies emerge to improve research efficiency and enable more targeted therapies, companies face new challenges in establishing differentiated go-to-market strategies, adapting to evolving reimbursement dynamics, and staying ahead of shifting customer needs.
Kx supports companies across a broad range of diagnostics and research tools to achieve and sustain growth.
How we support our diagnostics and
life science clients
Kx focuses on creating tailored strategies to support companies in the diagnostics and research tools space.
Our expertise includes:
- Acquisition due diligence
- Companion diagnostics commercialization
- Competitive differentiation strategies
- Customer segmentation
- Market landscaping and competitive intelligence
- Platform and menu optimization
- Product forecasting and opportunity assessments
- Reimbursement and economics analysis
Benefit from our diagnostics and
life sciences expertise
We bring deep experience from work with industry leaders and innovative new technologies to support our clients’ strategic imperatives.
We differentiate by providing high-impact, customized analysis and strategies informed by insights from market experts from independent and hospital-based labs, providers and administrators, payers, and industry leaders.
We support a range of tools and
- Clinical chemistry
- Companion diagnostics
- Mass spectrometry
- Molecular diagnostics
- Next-generation (next-gen) sequencing
- Personalized medicine
- Point-of-care testing